EuroGTP II: a tool to assess risk, safety and efficacy of substances of human origin-Reference-Cited by-同舟云学术

EuroGTP II: a tool to assess risk, safety and efficacy of substances of human origin

Published:2019-05-14 Issue:1 Volume:32 Page:80-84
ISSN:1353-4505
Container-title:International Journal for Quality in Health Care
language:en
Short-container-title:

Author:

Trias Esteve¹^ORCID,Lomas Richard²,Tabera Jaime¹,Piteira A Rita¹,Tilleman Kelly³,Casaroli-Marano Ricardo P¹,Chandrasekar Akila²,

Affiliation:

1. Banc Sang i Teixits (BST)—Barcelona Tissue Bank, Barcelona, Spain

2. National Health Service—Blood and Transplant (NHSBT). Liverpool, UK

3. Ghent University Hospital—Department of Reproductive Medicine, Ghent, Belgium

Abstract

Abstract A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin’ (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,Health Policy,General Medicine

Link

http://academic.oup.com/intqhc/article-pdf/32/1/80/33106711/mzz048.pdf

Reference16 articles.

1. The hidden research system: the evolution of cytogenetic testing in the national health service the hidden research system: the evolution of cytogenetic testing in the national health service;Hopkins;Sci Cult (Lond),2006

2. Beyond the dichotomy: a tool for distinguishing between experimental, innovative and established treatment;Provoost;Hum Reprod,2014

3. Getting clearer about surgical innovation: a new definition and a new tool to support responsible practice;Hutchison;Ann Surg,2015

4. IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage;Cook;BMJ,2013

5. IDEAL framework for surgical innovation 1: the idea and development stages;McCulloch;BMJ,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies;Therapeutics and Clinical Risk Management;2023-07

2. Development of a full-thickness acellular dermal graft from human skin: Case report of first patient rotator cuff patch augmentation repair;Transplant Immunology;2023-06

3. The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance;Cells;2022-07-05

4. Passive slow freezing is an efficacious and cost-effective alternative to controlled slow freezing for ovarian tissue cryopreservation;Cryobiology;2021-06

5. Risk Management;Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy;2021